HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.

AbstractOBJECTIVES:
Miltefosine, an orally effective antileishmanial drug, works directly on the parasite by impairing membrane synthesis and subsequent apoptosis of the parasite and has also been reported to have macrophage-activating functions that aid parasite killing. We investigated the type of immunological responses generated in miltefosine-treated Leishmania donovani-infected hamsters, which simulate the clinical situation of human kala-azar.
METHODS:
Twenty-five-day-old infected hamsters, treated with miltefosine at 40 mg/kg for 5 consecutive days, were euthanized on days 30 and 45 post treatment (p.t.) and checked for parasite clearance and for real-time analysis of mRNAs of the Th1/Th2 cytokines interferon-γ (IFN-γ), interleukin-12 (IL-12), tumour necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), IL-4, IL-10 and transforming growth factor-β (TGF-β), nitric oxide (NO) production, the lymphocyte transformation test (LTT) and antibody responses. Responses were compared with the normal and Leishmania-infected groups at the same time points.
RESULTS:
By day 45 p.t. there was a significant increase in the mRNA expression of iNOS, IFN-γ, IL-12 and TNF-α, whereas there were significant decreases in IL-4, IL-10 and TGF-β in cured hamsters as compared with their infected counterparts. In vitro stimulation of lymphocytes with concanavalin A and soluble Leishmania donovani antigen showed a maximum LTT response and there was a gradual increase in the NO level (∼7-fold compared with infected counterparts). Anti-Leishmania IgG and IgG1 levels, found to be elevated in the infected group, decreased significantly after treatment but there was a significant increase in IgG2 isotype.
CONCLUSIONS:
Treatment of Leishmania-infected hamsters with miltefosine reverses the Th2-type response into a strong Th1-type immune response.
AuthorsReema Gupta, Pramod K Kushawaha, Mukesh Samant, Anil K Jaiswal, Rajendra K Baharia, Anuradha Dube
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 67 Issue 2 Pg. 440-3 (Feb 2012) ISSN: 1460-2091 [Electronic] England
PMID22121191 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
  • Antiprotozoal Agents
  • Cytokines
  • RNA, Messenger
  • Phosphorylcholine
  • Nitric Oxide
  • miltefosine
Topics
  • Animals
  • Antibodies, Protozoan (blood)
  • Antiprotozoal Agents (administration & dosage)
  • Cell Proliferation
  • Cricetinae
  • Cytokines (biosynthesis)
  • Disease Models, Animal
  • Leishmania donovani (drug effects, immunology)
  • Leishmaniasis, Visceral (drug therapy, immunology)
  • Lymphocytes (immunology)
  • Nitric Oxide (metabolism)
  • Phosphorylcholine (administration & dosage, analogs & derivatives)
  • RNA, Messenger (analysis, genetics)
  • Real-Time Polymerase Chain Reaction
  • Th1 Cells (immunology)
  • Th2 Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: